Pramlintide
SymlinPen
NADAC/unit
$217.5214
No Shortage
vs. brand SymlinPen: Generic saves up to -2075% per unit
Active Shortages
2025-10-27 Discontinuation of the manufacture of the drug., AstraZeneca AB
2025-10-27 Discontinuation of the manufacture of the drug., AstraZeneca AB
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.